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A B S T R A C T
Introduction: One of the factors to influence abandoning breastfeeding is mothers’ use of medications. The www.
e-lactancia.org website is a reliable source in Spanish and English for online free-access information about the
compatibility of medications with breastfeeding. The aim of this study was to analyse the search profiles, and
groups and products, searched the most on this website.
Materials and methods: A retrospective and descriptive study of the e-lactancia.org website during 2014–2018.
Google Analytics was used for data collection. The following variables were analysed: number of users and
queries; professional profile; country; language; users’ and groups’ access modes/devices; most searched pro-
ducts.
Results: We found 16,821.559 users and 63,783.866 pages. Of users, 62.7 % were “mother/father”, and 31.9 %
were health professionals. Visits came mostly from: Spain (25.86 %); Mexico (16.87 %); Argentina (7.99 %);
Chile (7.31 %). The preferred access mode and device were organic searches (62.1 %) and mobile phones (73.4
%), respectively. Phytotherapy (14.4 %), antibacterial agents (12.3 %) and NSAIDs (12.3 %) were the most
searched groups, and ibuprofen (6.25 %) was the most popular product.
Conclusion: Users and consultations in e-lactation increased significantly during the study period. Mothers/fa-
thers were the main website users, followed by health professionals. The main consulted groups were anti-
bacterial agents, NSAIDs and systemic phytotherapy. Ibuprofen, paracetamol and amoxicillin stood out as the
most consulted products. These results revealed increase Internet resources use to solve parents and health
professionals’ breastfeeding doubts. Future research should study how users (parents, health professionals) in-
teract with this information.
1. Introduction
Non-compliance with the current World Health Organization
(WHO) recommendations on breastfeeding (BF), as fewer than 40 % of
infants younger than 6 months old exclusively receive breast milk as
food [1], poses a health risk for mothers and infants due to the in-
numerable benefits of breast milk as a protective factor against various
infections [2], cancers [3] and other diseases [4] in newborns and in-
fants. Regarding maternal health, BF promotes weight loss after child-
birth [5], prolongs amenorrhea and reduces risks of breast and ovarian
cancer, type 2 diabetes and cardiovascular disease [6]. BF improves the
health of mothers and babies worldwide [7].
Of the different factors that influence abandoning BF are use of
pacifiers [8], providing water to infants [9], the maternal perception of
low milk production, increasing infants’ low birth weight, maternal self-
efficacy levels [10,11] and mothers using medications [12–15]. Many
women take medications during BF [13,14], and up to 23 % of early
lactation interruptions are directly or indirectly associated with their
use [15–17].
Computer science, new technologies, physiological processes and
daily life currently overlap to the extent that there is constant health-
related information and learning sites on every website part. BF has not
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escaped this condition as many mothers seek information about BF for
their babies on the website [18].
The Global Digital Report 2018 [19] revealed that more than 4
billion people worldwide use the Internet; i.e., more than half of the
world’s population is online, and almost 250 million new users were
connected for the first time in 2017. The use of social media continues
to grow rapidly. Mmore than 3 billion people use it every month, and 9
in every 10 users employ mobile devices. As noted by Andrew Arnold,
“Parents have always sought out advice from others. Some generations
looked to their parents and grandparents. Others relied on books from ex-
perts like Benjamin Spock. Today, 71 % of millennials value the advice and
insights they receive from parenting blogs, parenting web sites, forums, and
social networks” [20].
Therefore, the combination of new technologies and social media
can influence BF rates. Health professionals also seek information on
the website, whose main common reason for using and retrieving in-
formation online is to bridge a knowledge gap [21,22].
In this article, the e-Health counselling tool www.e-lactancia.org
was studied based on health products with BF in order to analyse the
search profiles and groups and products that are most searched on this
website.
2. Materials and methods
A retrospective, comparative and descriptive study was conducted
of the data recorded by the e-Health e-lactancia.org tool from
01.01.2014 to 31.12.2018 (5 full years).
This tool was conceived due to the dispersion of information on BF
compatibility with taking drugs and medicinal plants, exposure to en-
vironmental pollutants or maternal diseases. It was created in 2000 in
the Paediatric Service of a hospital that had obtained the UNICEF Baby
Friendly Initiative accreditation in 1999 as a small database for using
the service. For convenience purposes, it was uploaded to the Internet
in 2002 and has grown since then with 1866 different products be-
longing to 192 groups, 8332 synonyms and 17,698 commercial brands
(from the Martindale list), although the database is linked with active
ingredients. e-lactancia.org contains 28,088 index terms.
The e-lactancia.org website has been recognised by prestigious or-
ganisations like the Academy of Breastfeeding Medicine, which has
recommended it in several of its articles and protocols [23,24], La
Leche League, iHan, the Grecia-Institute of Child’s Health in Greece, the
National Confederation of Pediatrics (Confederación Nacional de Pe-
diatría −CONAPEME) and the Breastfeeding Association (Asociación
Pro Lactancia Materna - APROLAM) in Mexico.
The e-lactancia.org website is composed of a search engine with
which the inquiring person can input the term with which (s)he intends
to assess compatibility with BF. The database returns a response, in-
cluding an explanatory comment and some pharmacokinetic data, both
based on the scientific literature, which are periodically updated and
reviewed in each researched product, disease or medication. In addi-
tion, the response classifies the risk and compatibility of BF in relation
to the searched product with the following easily interpretable colour-
code.
• Green-Very low risk: safe product, compatible with BF with suffi-
cient information published in the scientific literature or with more
than one of the following characteristics: lack of demonstrated
toxicity; frequent use in neonates or small infants with no side ef-
fects; extensive regular or traditional consumption; very favourable
pharmacokinetics; consensus of experts.
• Amber-Low risk: quite safe and most likely compatible. Its use could
have very mild adverse effects on BF or lactation. The physico-
chemical and pharmacokinetic characteristics of product absorp-
tion, distribution and elimination mean that the appearance of ad-
verse effects is very unlikely; such data have either been reported or
do not exist.
• Orange-High risk: unsafe, difficult compatibility. Evaluate carefully.
Use a safer alternative or interrupt BF for several T½ periods
(elimination half-life). Products considered high risk are those that
could have moderate or severe adverse effects on BF or lactation.
The physico-chemical and pharmacokinetic characteristics of pro-
duct absorption, distribution and elimination mean that the ap-
pearance of adverse effects is very unlikely; such data have either
been reported or do not exist.
• Red-Very high risk: very unsafe. Contraindicated. Use an alternative
or cease BF. The T½ of the drug is too long to consider temporary BF
interruption an alternative. Due to published data or the char-
acteristics of the substance, a high probability of it being toxic to the
infant or detrimental to lactation by inhibiting it is known or as-
sumed.
Each product can be searched directly by either its name or the
group to which it belongs, or by its trademark, a synonym and other
names in other scripts. When the product presents a high or a very high
risk, possible alternatives that are more compatible with BF (if any) are
presented through the same search. e-lactancia.org is regularly updated
by the APILAM group (Association for the Promotion and Scientific and
Cultural Research of Breastfeeding), a non-profit association. This
website is supported mainly by voluntary donations from mothers,
healthcare providers and breastfeeding support groups, and also by
teaming groups. APILAM is formed by four paediatricians, three phar-
macists and one nurse. It updates the database in several ways: when a
new alert is received from a database (mainly PubMed); when a user
writes to propose an update; systematically when the 100 most visited
products are updated.
2.1. Data collection and analysis
The Google Analytics tool was used for data collection. This tool
does not contain any personal data or confidential information, and
comes as aggregated data [25]. Among the variables that can be col-
lected through Google Analytics, and which were analysed globally and
disaggregated by year, we find: number of users, numbers of accesses
and queries, access languages, subcontinents and countries from which
access occurs, type of electronic device through which access is gained
(computer, tablet, mobile), professional user profile. Moreover, there
are sources of origin of the search and products about which user is
informed on the website: drugs, therapeutic groups, phytotherapy and
alternative products, contaminants and diseases. The level of risk as-
signed in e-lactancia.org was added to each analysed product.
A descriptive analysis was performed for all the variables using
absolute and relative frequencies expressed as percentages. The pair-
wise differences in years were calculated for devices and access chan-
nels by the chi-square test.
3. Results
Table 1 shows how the number of users of e-lactancia.org increased
year by year between 2014 and 2018, and went from 1.13 million in
2014 to 6.18 million in 2018. The numbers of sessions and page views
also rose. The total number of users during the study period
(2014–2018) was 16.8 million, with 63.8 million page views.
The subcontinents from which more web visits came were Central
America (+Mexico) (26.43 %), South America (24.62 %) and southern
Europe (18.99 %) (Fig. 1). The most prominent countries were Spain
(25.86 %), Mexico (16.87 %), Argentina (7.99 %), Chile (7.31 %),
Colombia (5.43 %), Peru (3.27 %), the United States (2.82 %), Russia
(2.64 %) and Portugal (1.94 %).
The main language used by access devices was Spanish (76 %),
followed by English (8.5 %), Portuguese (4.2 %) and Russian (4%).
The access channels to e-lactancia.org were through “organic”
searches (not paid) on search engines (62.1 %), by direct URLs (23.8
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%), from social networks (8.2 %) and through links from other websites
(5.8 %), with mobile phones (73.4 %) as the most widely used access
device, followed by personal computers (22.6 %) and tablets (4.0 %).
Tables 2 and 3 show the annual increases between 2014 and 2018 of
mobile phones as an access device to e-lactancia.org and of “organic”
searches as an access channel, respectively. Statistically significant
differences were found between all the pairs of years analysed by de-
vices and access channels (p< 0.05).
The most frequently found professional profile (25.1 % declared)
was “mother/father” (62.7 %), followed by “health professionals” (31.9
%, including 8% paediatricians, 5.3 % nurses and 3.4 % midwives) and
“consultants/support groups” (3.16 %).
Product queries on the website came to 30,623,967. Table 4 shows
the numbers and percentages of the most researched groups.
Among the most searched products per group, the following stood
out (percentages of the total number of visits): antibacterial agents,
amoxicillin (2.3 %); NSAIDs, ibuprofen (6.25 %); phytotherapy, fennel
(0.85 %); analgesics, paracetamol (2.77 %); antihistamines, loratadine
(1.73 %); diet supplements, coffee (0.64 %); maternal diseases, urinary
infection (0.23 %); maternal activities, tattooing (0.65 %); anti-ulcer
medicines, omeprazole (1%); drugs of abuse, alcohol (1.38 %); con-
traceptives, levonorgestrel (0.54 %); anxiolytics, diazepam (0.48 %);
decongestants, phenylephrine (0.61 %); antidepressants, sertraline
(0.42 %). Tables 5a and 5b shows the 75 most searched products, which
accounted for 50 % of the total number of queries during the study
period. This table also includes a column with the risk level assigned on
the e-lactancia.org website.
4. Discussion
The e-lactancia.org tool very significantly increased as far as users
are concerned from year to year: the number of visits increased 10-fold
from 2014 to 2018.
One of the factors to explain these millions of annual visits to e-
Table 1
Numbers of users, sessions and pages and average pages per session visited by
users of e-lactancia.org during the study period (2014-2018).
Year Users Sessions Pages Pages/Session
2014 1,127,540 1,741,230 6,073,393 3.49
2015 1,943,901 3,093,853 9,278,509 3.00
2016 3,035,356 4,623,224 11,641,765 2.52
2017 4,532,746 6,800,107 16,580,344 2.44
2018 6,182,016 9,471,137 20,209,855 2.13
Total 16,821,559 25,729,551 63,783,866 2.48
Fig. 1. Visits to www.e-lactancia.org by subcontinents.
Table 2
Access channels to e-lactancia.org used by users during 2014-2018. Number
and percentage of total annual access and total.
Year Organic search Direct Social Referral
N % N % N % N %
2014 448,776 46.8 287,548 30.0 74,213 7.7 148,207 15.5
2015 938,237 56.6 412,430 24.9 140,100 8.4 167,763 10.1
2016 1,448,644 57.2 647,239 25.6 222,597 8.8 211,729 8.4
2017 2,309,335 64.0 831,459 23.0 319,108 8.9 147,994 4.1
2018 3,237,721 68.5 1,047,649 22.2 335,782 7.1 102,605 2.2
Total 8,382,713 62.2 3,226,325 23.9 1,091,800 8.1 778,298 5.8
Organic Search: Traffic from unpaid search on any search engine; Direct:
Sessions during which the user typed the name of your website URL into the
browser or came to your site via a bookmark; Social: Traffic from any of ap-
proximately 400 social networks (not tagged as ads); Referral: Traffic from
websites that are not social networks.
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lactancia.org is lack of scientific information in the lactation section of
the brochures and fact sheets prepared by the pharmaceutical industry
for its products [26,27]. A short phrase very often indicates that the
drug is contraindicated during BF (or BF “should be discontinued while
taking medication”, which completely ignores how complicated it can
be to interrupt and resume BF, and disregards the proven benefits of BF
for mothers and infants). No evidence for this claim is offered or, at the
most, it states that medication can pass to breast milk, or in animals
(generally rats), it has been detected in breast milk. Nor do they report
the amount excreted or the possible or proven problems for either in-
fants or BF. This biased legal-defensive information [26] in pro-
spectuses has conditioned medical professionals to systematically deny
the compatibility of BF with taking any medication despite the paucity
of according evidence because few or no reactions observed in infants
can be definitively attributed to nursing mothers taking medications
[15].
With the advent of the information society, and the rise in and
importance attached to BF at the start of in the 1990s, this model of
absolute incompatibility between BF and medications, and the work of
pioneering specialists like Briggs (Drugs in Pregnancy and Lactation,
1983), Dr. Bennet (Drugs and Human Lactation, 1988) and Dr. Hale
(Medications and Mother's Milk, 1992), reached professionals and the
general public. The creation of the LactMed website (https://toxnet.
nlm.nih.gov/newtoxnet/lactmed.htm) in 2003 by Dr. P.O. Anderson
contributed to this change [28].
The fact that e-lactancia.org is a free-access Internet database based
on scientific and up-to-date data, and one that is easy and intuitive
managed, allowed us to quickly obtain accurate information, which
explains the very large number of queries.
The number of health professionals concerned about maintaining BF
is increasing, and they should have accurate information about the
compatibility of medications and BF to advise them in their decision
making [26,27]. The e-lactancia.org website offers a clear advantage: as
it is a digital tool, it allows rapid information dissemination and data
can be updated in real time, as highlighted in some articles [29,30]. It
also helps to avoid the main barrier detected in using online informa-
tion, especially in the primary healthcare field: lack of time [31].
Although the e-lactancia.org website is designed to help profes-
sionals, the concise style of its comments and its intuitive way of
showing the risk level on a traffic light scale have led to mothers
themselves being its most frequent users for years, who account for
almost two thirds of visits. The e-lactancia.org website allows BF mo-
thers’ active participation in clinical decisions that can affect BF, which
can end in the decision to abandon it [30,32], and limit mothers’
Table 3
Type of device used to access e-lactancia.org during (2014-2018), n and (%).
Year Mobile Desktop Tablet Total
n % n % n % n %
2014 413,880 46.5 388,501 43.6 88,590 9.9 890,971 100.0
2015 960,680 61.1 493,314 31.4 117,874 7.5 1,571,868 100.0
2016 1,732,401 72.2 547,969 22.9 117,473 4.9 2,397,843 100.0
2017 2,659,552 77.1 679,215 19.7 109,706 3.2 3,448,473 100.0
2018 3,704,604 81.1 770,963 16.9 92,520 2.0 4,568,087 100.0
Total 9,038,072 73.4 2,783,090 22.6 494,835 4.0 12,315,997 100.0
Table 4
Number of searches grouped as therapeutic group and percentage of total
(30,623,967) searches on e-lactatancia.org products during 2014-2018.
Groups Search
A %
Antibacterial agents 3,761,124 12.28
NSAIDs 3,757,563 12.27
Systemic phytotherapy 3,377,574 11.03
Analgesics 1,721,999 5.62
Antihistamines 1,705,804 5.57
Diet supplements 1,258,784 4.11
Topical phytotherapy 1,042,251 3.40
Maternal disease 762,402 2.49
Maternal activities (sports, cosmetic, sanitary, etc.) 702,484 2.29
Anti-acid reflux 658,001 2.15
Drug abuse 649,172 2.12
Contraceptives 592,223 1.93
Anxiolytics, hypnotics and sedatives 545,925 1.78
Decongestants 532,838 1.74
Antidepressants 460,181 1.50
NSAIDs: non-steroidal anti-inflammatory agents.
Table 5a
Most visited products, 2014-2018 (5 years), number of searches and percentage
of all (30,623,967) the product searches. Level of risk assigned in e-lactancia.
Product name No. of visits % e-lactancia risk *
1 Ibuprofen 1,913,392 6.25 0
2 Paracetamol 848,758 2.77 0
3 Amoxicillin 702,820 2.30 0
4 Loratadine 530,239 1.73 0
5 Diclofenac 519,635 1.70 0
6 Alcohol (drinks) 420,894 1.37 2
7 Amoxicillin-clavulanic acid 328,487 1.07 0
8 Chlorphenamine 322,721 1.05 1
9 Ciprofloxacin 314,572 1.03 0
10 Omeprazole 308,083 1.01 0
11 Naproxen 307,077 1.00 1
12 Cetirizine hydrochloride 276,172 0.90 0
13 Metoclopramide 272,303 0.89 0
14 Ketorolac-trometamol 263,121 0.86 0
15 Fennel 261,202 0.85 2
16 Ginger 251,897 0.82 0
17 Azithromycin 244,659 0.80 0
18 Metronidazole 232,796 0.76 0
19 Metamizole 214,585 0.70 1
20 Chamomile 208,983 0.68 0
21 Cephalexin 208,605 0.68 0
22 Tattoo 199,657 0.65 1
23 Coffee 195,870 0.64 1
24 Phenylephrine 186,543 0.61 1
25 Aspirin 185,630 0.61 1
26 Dexamethasone 172,378 0.56 1
27 Levonorgestrel 165,360 0.54 0
28 Ranitidine 160,014 0.52 0
29 Acetylcysteine 159,442 0.52 0
30 Ambroxol 152,246 0.50 0
31 Diazepam 147,454 0.48 1
32 Dextromethorphan 146,980 0.48 0
33 Domperidone 143,948 0.47 0
34 Clindamycin 143,900 0.47 1
35 Tramadol 139,083 0.45 0
36 Local anesthesia 137,887 0.45 0
37 Clotrimazole 135,267 0.44 0
38 Fluconazole 134,980 0.44 0
39 Pennyroyal 134,641 0.44 2
40 Ampicillin 133,520 0.44 0
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perception that the medication, if necessary, can be harmful during BF
[33].
Conversely in most countries, the usual ratio between the number of
mothers and that of professionals rarely exceeds 10 doctors and 10
nurses per thousand inhabitants [34]; that is, less than 2% on the
whole, and 32 % of users are health professionals. These proportions
indicate the trust and usefulness that physicians, nurses, midwives,
pharmacists and other health professionals place in e-lactancia.org.
The fact that Spanish-speaking countries are the source of most
visits and Spanish is the most widely used language for access devices
are explained by the origin of the site’s creation. Nevertheless, it has
reached other countries, such as the United States and Russia, and is
accessed in languages like English, Portuguese and Russian [35].
Despite e-lactancia.org not having as an application (app) intended
for tablets or smartphones, the responsive or adaptive web design of e-
lactancia.org since 2013 has led to most accesses occurring via mobile
phones rather than personal computers and tablets, which falls in line
with Internet users’ current trends [35].
In 5 years, 63.8 million entries to the e-lactancia.org website were
counted, of which slightly less than half (30.6 million) were product
visits (medications, plants, diseases, others) because most users enter e-
lactancia.org through the landing page to search for a desired product.
There are also several pages on e-lactancia.org that are not product-
related, like a page to make donations, a page for sponsors, a page for
endorsements, the “About us” page and a page for statistics, which users
also visit.
The most searched products on the e-lactancia.org tool reflect,
among professionals, both the most prescribed and those that suggest
doubts about compatibility with BF. Among mothers, the most con-
sumed are those related to their concerns about the compatibility of
their use during lactation [16]. These patterns are distributed similarly
to that indicated in other studies [14].
As adequate accessible information is lacking, professionals often
recommend mothers interrupting BF [13,16], although few products
are absolutely contraindicated [15,32,36]. Hence it would be appro-
priate to make a risk assessment and search before making a decision
[13,37].
The most searched groups of drugs were antibacterial and non-
steroidal anti-inflammatory drugs (NSAIDs), with more than 3.7 million
visits each, followed by analgesics and antihistamines (1.7 million
views each). However, when we added systemic and topical phy-
totherapy products together, phytotherapy was the most searched
product group, with 4.8 million visits in all, which reflects the high
level of approval of these products by nursing mothers and some pro-
fessionals [38]. The authors of e-lactancia.org emphasise that biblio-
graphic references on phytotherapy products and lactation are often
missing, which would make an adequate risk assessment difficult.
Of the 1866 products referenced in e-lactancia.org, only 75 account
for 50 % of total visits, with ibuprofen at the top (1.9 million visits),
followed in this order by: paracetamol, amoxicillin, loratadine and di-
clofenac (with more than half a million visits each). It is noteworthy
that the sixth most searched product is alcohol, which reflects mothers’
concern about the effects that alcohol consumption may have on BF or
their infant. In addition to discouraging it, it is advisable to well report
the waiting times for BF and to avoid co-sleeping after drinking because
approximately half western BF mothers consume alcohol during BF
[39]. Of these 75 most visited products, only two, star anise and co-
caine, are classified on e-lactancia.org as a very high risk, six are
classified as high risk, and the remainder as low or very low risk.
On 30 June, 2015, the Food and Drug Administration (FDA) of the
United States published new recommendations on the labelling of drugs
and products: the Pregnancy and Lactation Labeling Rule (PLLR)
[30,40]. This forced a change in the subsection entitled “Nursing Mo-
thers” to “Lactation”, which should be divided into three sections: Risk
Summary, a summary of drug absorption; concentration in milk; the
actual or estimated daily dose for infants; the effect of the drug on milk
production; a risk/benefit statement; Clinical considerations, which de-
scribes recommendations about how to minimise exposure to a drug
and how to control undesirable side effects; Data Section, which should
include all the available studies supporting the summary of risk as-
sessments. In addition, whenever there data are available for humans,
no animal data should be included [30,40]. e-lactancia.org complies
with these FDA requirements, which have gradually been implemented
until 2020. Furthermore, e-lactancia.org includes the following: pro-
duct name, synonyms, chemical formula; the Anatomical, Therapeutic,
Chemical Classification System (ATC); date of the last update of the last
searched product or medication; if there has been any change in the risk
level; a comment with data on absorption and excretion in breast milk;
estimated dose for infants; possible effects on infants or lactation; as-
signing the risk level on a colour-coded scale (green: very low risk;
amber: low risk; orange: high risk; red: very high risk); possible safer
alternatives, as shown in Fig. 2; pharmacokinetics data; the list of re-
ferences consulted to make recommendations (none of these should be
accompanied by animal data); finally, a list of trademarks.
5. Conclusion
The number of users and consultations in e-lactation significantly
increased during the study period. Mothers and fathers were the main
website users, followed by health professionals. The main consulted
Table 5b
Most visited products, 2014-2018 (5 years). Number of visits and percentage of
the total.
Product name No. of visits % e-lactancia risk
*
41 Acyclovir 128,890 0.42 0
42 Betamethasone 128,274 0.42 1
43 Sertraline hydrochloride 127,857 0.42 0
44 Pseudoephedrine 125,383 0.41 1
45 Caffeine 124,715 0.41 1
46 Metformin hydrochloride 124,210 0.41 0
47 Ketoprofen 124,152 0.41 0
48 Anise 123,712 0.40 1
49 Desloratadine 122,753 0.40 0
50 Prednisone 121,189 0.40 0
51 Lorazepam 120,102 0.39 0
52 Lidocaine 117,327 0.38 0
53 Sodium bicarbonate 114,242 0.37 0
54 Nimesulide 111,798 0.37 2
55 Valerian 107,671 0.35 1
56 Tobacco 106,872 0.35 2
57 Ceftriaxone sodium 105,962 0.35 0
58 Clonazepam 101,787 0.33 1
69 Loperamide hydrochloride 101,492 0.33 0
60 Cinnamon 101,089 0.33 0
61 Sulpiride 95,178 0.31 0
62 Codeine 93,549 0.31 2
63 Tea 91,588 0.30 1




66 Star anise 85,344 0.28 3
67 Clarithromycin 85,331 0.28 0




70 Levofloxacin 83,058 0.27 1
71 Linden 82,981 0.27 0
72 Mint 81,009 0.27 0
73 Hair dyes 80,614 0.26 1
74 Beer yeast 80,570 0.26 0
75 Yerba mate 80,018 0.26 0
* Level of risk assigned in e-lactancia: 0: Very low (green), 1: low (amber), 2:
high (orange), 3: very high (red).
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groups were antibacterial agents, NSAIDs and systemic phytotherapy.
The main consulted products that sttod out were ibuprofen, para-
cetamol and amoxicillin.
These results are very interesting because they reveal an increased
use of this web resource, and probably other similar ones, to solve
doubts about the compatibility of drugs and other substances with BF.
In addition, determining the main consulted groups and products opens
up work lines in order to, for example, improve health professionals’
education and to attract those parents interested in BF. Future research
about how users (parents and health professionals) interact with this
information should be conducted.
Summary table
• We provide relevant data about visits, user profiles and most
visited products on the www.e-lactancia.org website
• We observed how this website was increasingly accepted
given its compatibility with breastfeeding
• The increased visits by health professionals was noteworthy
and in accordance with technological evolution as websites
Fig. 2. Example of the data shown when consulting a product at www.e-lactancia.org.
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can now be accessed with mobile phones
• It has been shown as a tool for determining the compatibility
of many products with breastfeeding, it is scientifically en-
dorsed and it complies with Food and Drug Administration
recommendations
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